Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1001-1010 of 3545 for cancer

Edit search filters
  1. A Clinical Study To Assess The Efficacy And Safety Of Alpha DaRT224 For The Treatment Of Patients With Recurrent Cutaneous Squamous Cell Carcinoma

    Rochester, MN

  2. Tucatinib and Trastuzumab for Patients with HER2-positive Metastatic Colorectal Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  3. Cediranib Maleate and Selumetinib in Treating Patients With Solid Malignancies

    Jacksonville, FL, Rochester, MN

  4. Tai Chi on Colorectal Cancer Survivors With Fatigue

    Scottsdale/Phoenix, AZ

  5. Phase 3 Trial of Autologous Dendritic Cell Immunotherapy (AGS-003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (RCC)

    Scottsdale/Phoenix, AZ

  6. Combination Of Serabelisib And Insulin Suppressing Diet In Subjects With Advanced Solid Tumors With PIK3CA Mutations

    Rochester, MN

  7. PERT for Treatment of Exocrine Pancreatic Insufficiency in Patients With Unresectable Pancreatic Cancer

    Jacksonville, FL

  8. A Study to Evaluate Intravenous Ascorbic Acid (Vitamin C) as an Adjunct to Pazopanib in the First-Line or Post-immunotherapy Setting for Metastatic or Unresectable Clear Cell Renal Cell Carcinoma (ccRCC)

    Rochester, MN

  9. A Study To Compare Durvalumab Vs Placebo Following Stereotactic Body Radiation Therapy In Early Stage Non-small Cell Lung Cancer Patients

    Rochester, MN

  10. Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

    Rochester, MN, La Crosse, WI

.

Mayo Clinic Footer